Faculty profile

Zeny Feng

ResearcherMathematics and StatisticsUniversity of Guelph

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Guelph directory, so their courses may be missing. Find their university profile.

Zeny Feng

Researcher

Mathematics and Statistics

University of Guelph

Guelph, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 8 research grants (7 NSERC, 1 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

metagenomic microbiome compositional data statistical bioinformatics environmental data regularization machine learning neural network embedding method

Latest papers

Impact of Hepatitis C screening and treatment among incarcerated populations in Alberta, Canada on population-level Hepatitis C elimination efforts.
The International journal on drug policy · 2026
Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development.
JMIR public health and surveillance · 2025
Inactivation Kinetics of Alicyclobacillus acidoterrestris Spores and Determination of Spore Germicidal Fluences Under UV-C Treatment.
Journal of food protection · 2025

All 31 publications

Latest funding

Smart Screening for Hepatitis C: A Machine Learning Approach to Find Undiagnosed Infection in Canada
CIHR · 2026 · Principal investigator
$852,976
Statistical and computational methods for environment, life, and health.
NSERC · 2024 · Principal investigator
$34,000
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
CIHR · 2023 · Co-investigator
$100,000

All 16 grants and awards

31 publications.

Impact of Hepatitis C screening and treatment among incarcerated populations in Alberta, Canada on population-level Hepatitis C elimination efforts.

Tian F, Kronfli N, Eze N, Feng Z, Clement F, Wong WWL

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2026.105201 PMID: 41734536

Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development.

Smith-Roberge J, Forouzannia F, Hamadeh A, Feng Z, Popovic N, Wong WWL

JMIR public health and surveillance2025

DOI: 10.2196/66309 PMID: 40835390

Inactivation Kinetics of Alicyclobacillus acidoterrestris Spores and Determination of Spore Germicidal Fluences Under UV-C Treatment.

Das Q, Arvaj L, Cooper A, Feng Z, Sasges M, Patras A, Khursigara CM, Balamurugan S

Journal of food protection2025

DOI: 10.1016/j.jfp.2025.100473 PMID: 40023402

Tests of covariate effects under finite Gaussian mixture regression models.

Gan C, Chen J, Feng Z

Journal of applied statistics2025Senior author

DOI: 10.1080/02664763.2024.2433567 PMID: 40497154

Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries.

Tian F, Forouzannia F, Feng Z, Biondi MJ, Mendlowitz AB, Feld JJ, Sander B, Wong WWL

Hepatology (Baltimore, Md.)2024

DOI: 10.1097/hep.0000000000000779 PMID: 38478751

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.

Forouzannia F, Hamadeh A, Passos-Castilho AM, Erman A, Yu A, Feng Z, Janjua NZ, Sander B, Greenaway C, Wong WWL

Liver international : official journal of the International Association for the Study of the Liver2024

DOI: 10.1111/liv.15875 PMID: 38445848

CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.

Masucci L, Tian F, Tully S, Feng Z, McFarlane T, Chan KKW, Wong WWL

Medical decision making : an international journal of the Society for Medical Decision Making2024

DOI: 10.1177/0272989x241234070 PMID: 38486447

Urinary Metabolite Profiling to Non-Invasively Monitor the Omega-3 Index: An Exploratory Secondary Analysis of a Randomized Clinical Trial in Young Adults

MacIntyre BC, Shanmuganathan M, Klingel SL, Kroezen Z, Helmeczi E, Seoh N-Y, Martinez V, Chabowski A, Feng Z, Britz-McKibbin P

Metabolites20235 citationsOpen Access

DOI: 10.3390/metabo13101071 PMID: W4387576629

ATQ: alert time quality, an evaluation metric for assessing timely epidemic detection models within a school absenteeism-based surveillance system.

Vanderkruk KR, Deeth LE, Feng Z, Trotz-Williams LA

BMC public health2023

DOI: 10.1186/s12889-023-15747-z PMID: 37165339

Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings.

Wong WWL, Wong J, Bremner KE, Saeed Y, Mason K, Phoon A, Martel-Laferrière V, Bruneau J, Feld JJ, Feng Z, Baguley E, Lee SS, Powis J, Krahn MD

Liver international : official journal of the International Association for the Study of the Liver2023

DOI: 10.1111/liv.15518 PMID: 36606706

Smart Screening for Hepatitis C: A Machine Learning Approach to Find Undiagnosed Infection in Canada

Principal investigatorCIHR2026Project Grant

Principal investigators: Wong, William Wai Lun; Feng, Zeny Z; Mendlowitz, Andrew B

Keywords: Health Administrative Data; Hepatitis C; Machine Learning; Undiagnosed Population

$852,976

Statistical and computational methods for environment, life, and health.

Principal investigatorNSERC2024Discovery Grants Program - Individual

Principal investigators: Feng, Zeny

Keywords: metagenomic microbiome; compositional data; statistical bioinformatics; environmental data; regularization; machine learning; neural network; embedding method; mixture models; mm algorithm

$34,000

Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada

Co-investigatorCIHR2023Cat. Gr.: STBBI Res.: Beyond HIV/AIDS/Hep. C- STBBI other than HIV/hep. C (gen.)

Principal investigators: Wong, William Wai Lun

Keywords: Hepatitis B; Mathematical Modelling; Prevalence

$100,000

Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion

Co-investigatorCIHR2022Cat Gr.: Policy Research for HST - IHSPR - Health Care Policy Res./Systems Res.

Principal investigators: Wong, William Wai Lun; Popovic, Nashira

Keywords: Hepatitis C; Mathematical Modelling; Prevalence

$150,000

Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting

Co-investigatorCIHR2021Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Wong, William Wai Lun; Chan, Kelvin K; Prica, Anca

Keywords: Chimeric Antigen Receptor T-Cells; Cost-Effectiveness Analysis; Health Utility; Out-Of-Pocket Costs; Quality Of Life; Time Costs

$100,000

Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data

Co-investigatorCIHR2021Catalyst Grant: STBBI Research in Canada: Beyond HIV/AIDS/Hepatitis C - General

Principal investigators: Wong, William Wai Lun

Keywords: Hepatitis B; Mathematical Modelling; Prevalence

$100,000

Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work

Co-investigatorCIHR2020Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Wong, William Wai Lun; Chan, Kelvin K

Keywords: Chimeric Antigen Receptor T-Cells; Cost-Effectiveness Analysis; Health Utility; Out-Of-Pocket Costs; Quality Of Life; Time Costs

$100,000

Investigating novel quantitative genetics approaches in barley genetics

Co-investigatorNSERC2020Alliance Grants

Principal investigators: Lukens, Lewis LN

$222,000

Towards eliminating viral hepatitis - Addressing hepatitis B using a multidisciplinary approach

Co-investigatorCIHR2019Project Grant - Priority Announcement: Infection and Immunity

Principal investigators: Wong, William Wai Lun; Sander, Beate H

Keywords: Cost-Effectiveness Analysis; Hepatitis B; Infectious Disease Model; Out-Of- Pocket Costs; Policy Model; Preferences; Quality Of Life; Time Costs; Utility

$100,000

Statistical methods for genetic and bioinformatic studies

Principal investigatorNSERC2019Discovery Grants Program - Individual

Principal investigators: Feng, Zeny

Keywords: Breeding strategy; Differential abundance analysis; Dirichlet Multinomial; Genetic association study; Genomic evaluation; metagenomic data analysis; Missing data; Monte Carlo expectation-maximization; Post selection inference; virome sequencing data

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Zeny Feng

Research

Latest papers

Latest funding

Impact of Hepatitis C screening and treatment among incarcerated populations in Alberta, Canada on population-level Hepatitis C elimination efforts.

Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development.

Inactivation Kinetics of Alicyclobacillus acidoterrestris Spores and Determination of Spore Germicidal Fluences Under UV-C Treatment.

Tests of covariate effects under finite Gaussian mixture regression models.

Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries.

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.

CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis.

Urinary Metabolite Profiling to Non-Invasively Monitor the Omega-3 Index: An Exploratory Secondary Analysis of a Randomized Clinical Trial in Young Adults

ATQ: alert time quality, an evaluation metric for assessing timely epidemic detection models within a school absenteeism-based surveillance system.

Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings.

Smart Screening for Hepatitis C: A Machine Learning Approach to Find Undiagnosed Infection in Canada

Statistical and computational methods for environment, life, and health.

Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada

Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion

Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting

Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data

Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work

Investigating novel quantitative genetics approaches in barley genetics

Towards eliminating viral hepatitis - Addressing hepatitis B using a multidisciplinary approach

Statistical methods for genetic and bioinformatic studies

Frequent collaborators

Beate Sander

Murray Krahn

Rob Deardon

Gerarda Darlington

Jess Haines

Julie Bruneau

Doug Klein

Kelly Grindrod

Nadine Kronfli

Paula Brauer

Nicholas Mitsakakis

Jiahua Chen

Philip Britz Mckibbin

Angelo Tremblay

Fiona Clement

Christina Greenaway